Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion type Assertion NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_head.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion description "[Three SNPs located in the 3' region of SEPP1, which is overlapping with the promoter region of an antisense transcript, were significantly associated with adenoma risk: homozygotes at two SEPP1 loci (31,174 bp 3' of STP A>G and 43,881 bp 3' of STP G>A) were associated with increased adenoma risk [odds ratio (OR), 1.48; 95% confidence interval (95% CI), 1.00-2.19 and OR, 1.53; 95% CI, 1.05-2.22, respectively] and the variant SEPP1 44,321 bp 3' of STP C>T was associated with a reduced adenoma risk (CT versus CC OR, 0.85; 95% CI, 0.63-1.15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_provenance.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion evidence source_evidence_literature NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_provenance.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion SIO_000772 18483336 NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_provenance.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion wasDerivedFrom befree-2016 NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_provenance.
- NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_assertion wasGeneratedBy ECO_0000203 NP671326.RA5CB2eTC6EO7EQEmybsKreaUnsKXRwtG0Nc2OH1fXI1g130_provenance.